Breast Cancer Side Population Versus CD44(+)/CD24(-) Cells: Functional and Tumorigenic Differences. Osawa Y, Kumazaki A, Imanaka K, Ohmoto Y, et al. Anticancer Res 2026;46:6041-6050.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Osawa Y, Kumazaki A, Imanaka K, Ohmoto Y, et al. Breast Cancer Side Population Versus CD44(+)/CD24(-) Cells: Functional and Tumorigenic Differences. Anticancer Res 2026;46:6041-6050.
PMID: 42946447